The following is a review of diagnostic product developments worldwideThe information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.
The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
Product developments in October 2005
Advance Nanotech, Inc., is financing the development of BiMAT, a biosensor technology for rapid infectious disease testing. BiMAT is developing integrated, low cost and disposable sensors and sensor arrays for point of care diagnostics, clinical monitoring and biomolecular research. The investment in BiMAT was made in partnership with The Center for Advanced Photonics and Electronics at the University of Cambridge UK.
Beckman Coulter is buying privately held Diagnostic Systems Laboratories Inc. for $138 million. DSL had 2004 sales of about $34 million of immunoassays for research in reproductive and cardiovascular health.
BioGenex Laboratories Inc. received FDA clearance to market its InSite HER-2/neu (CB11) Monoclonal Antibody immunohistochemical test. InSite HER- 2/neu (CB11) is available as a ready-to-use reagent, in manual and automated formats, and is allowed for use with BioGenex's i6000 Automated Staining System and the Optimax Plus Consolidated Staining System.
Bridgetech Holdings International, Inc. has formed a collaboration with the University of Texas M. D. Anderson Cancer Center to develop a prognostic to identify women who are at increased risk of developing recurrent cervical cancer. Certain cell-mediated immune responses signal the need for an increase in the frequency and types of testing done.
Cholestech Corporation is providing a high sensitivity C-Reactive Protein (hs-CRP) test for the Cholestech LDX System to rapidly pre-screen patients for eligibility to participate in a global multi-site clinical study, sponsored by AstraZeneca. The AstraZeneca clinical trial is designed to investigate the effect of a statin in the primary prevention of cardiovascular events in patients with normal to low cholesterol levels but elevated hs-CRP.
DMetrix, Inc. introduced the DX-40 Array Microscope, a digital-imaging device that combines 80 miniature microscope objectives in a single instrument. The DX-40 captures a 900 Megapixel image in less than 60 seconds which can then be stored in a web-based program.
Home Diagnostics, Inc. received FDA clearance to market the Sidekick, the world's smallest blood glucose monitor built on top of a vial of 50 test strips.
Sysmex America released specialized IPF and RET-He software programs for the Sysmex XE-2100 hematology analyzers. The software allow the Sysmex XE-2100 system to measure immature forms of platelets and quantify reticulocyte hemoglobin.
Product developments - September 2005
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links
Send mail to email@example.com with questions or comments about this web site.
Concept and Design Blue Page
Last modified: November 2, 2005